Stromal Sarcoma — Trials

Stromal Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 40%
Top sponsor: Centre Leon Berard
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06655246	A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	recruiting	Phase 1	157	Kura Oncology, Inc.INDUSTRY	1	Feb 5, 2026	clinicaltrials
NCT04811196	A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients	completed	Phase 1	56	University Health Network, TorontoOTHER	1	May 29, 2025	clinicaltrials